2026 Is a Global UDI Turning Point — Are You Ready?
Major medical device UDI requirements are taking effect across the EU, Australia, and Switzerland. Ensure your compliance strategy is aligned before deadlines arrive
What’s Changing in 2026
Global UDI Requirements Are Expanding
Health authorities around the world are mandating Unique Device Identification (UDI) requirements and 2026 marks a critical milestone year.
- EU (EUDAMED): Mandatory use of four modules including UDI/Device starts May 28, 2026
- Australia (AusUDID): First phased deadline for Class III & IIb medical devices is July 1, 2026
- Switzerland (swissdamed): Mandatory use of the Product Module begins July 1, 2026
For medical device manufacturers operating across multiple markets, these compliance dates introduce new data submission, maintenance, and lifecycle management obligations.
Managing UDI in one region is complex. Managing it across multiple regions requires a coordinated global strategy.
The Complexity of Global UDI Compliance
Each regulatory system has unique data structures, submission requirements/methods, and timelines. Yet your product data must remain:
- Accurate
- Continuously maintained
- Synchronized
- Retained
- Audit-ready
Disconnected processes increase risk — from submission errors to inspection findings to market access delays.
One Partner for Global UDI Compliance
LexisNexis Life Sciences simplifies global UDI management.
We support medical device manufacturers across the entire product lifecycle, from initial UDI data collection, preparation, and submission to ongoing updates, change management, and post-market compliance.
Our technology-driven solutions and global regulatory expertise help ensure your medical device data remains compliant across EUDAMED, AusUDID, swissdamed and other health authority databases—reducing operational burden and regulatory risk.
You focus on innovation. We help safeguard compliance.
Explore 2026 UDI Resources
The State of Global Regulatory Compliance 2026
The European Commission formally confirmed in the OJEU that the Actors, UDI/Devices, Notified Bodies/Certificates, and Market Surveillance modules meet the required specifications.
Breaking Down the EU’s Latest EUDAMED Functional Confirmation
The European Commission formally confirmed in the OJEU that the Actors, UDI/Devices, Notified Bodies/Certificates, and Market Surveillance modules meet the required specifications.
Swissmedic Launches UDI Module in swissdamed
Voluntary submissions begin in August 2025, with mandatory registration starting July 2026. The system aligns with EUDAMED standards, compliance, and post-market surveillance.
EUDAMED Rollout Delay: What It Means for Medical Device
The European Commission did not declare EUDAMED “fully functional” by the previously anticipated July 1, 2025 deadline, and no notice was published in the Official Journal of the EU.
Leverage Our Expertise in Life Sciences
Medical Device
Pharmaceuticals
450+
Global Medical Device clients
33%
Medical Device UDI records electronically submitted to US FDA GUDID
1,000,000+
Medical Device UDI records submitted globally
1,000+
Global Pharmaceutical clients
20+
Years of Pharma SPL service
99.95%
Pharma FDA SPL submissions delivered within contracted time
Prepare for 2026 UDI Compliance
Complete the form to connect with the LexisNexis Life Sciences team about your global UDI compliance needs. We’ll follow up to discuss how to support your strategy across EUDAMED, AusUDID, and swissdamed ahead of 2026 requirements.
